Table 3. Gabapentin Groups Presented Lower PAED and CHIPP Scores Than the Placebo Group at Time 30^a,b.

	Groups			P Valuec
Variables	Placebo	15 mg/kg GABA	30 mg/kg GABA
PAED	10.33 ± 6.11 A,B	2.61 ± 4.94 A	2.63 ± 5.06 B	< 0.001d A,B
CHIPPS	2.42 ± 2.45 C,D	0.63 ± 1.43 C	0.65 ± 1.85 D	< 0.001d C,D

^a15 and 30 mg/kg gabapentin groups had lower PAED and CHIPP mean scores than the placebo group at time 30 (p a,b < 0.001). PAED scores of above 10 were presented in the placebo group. All gabapentin patients had PAED scores of below 10. PAED and CHIPP mean scores at time 0 were not shown because patients were always sedated at this point.

^bA, C Placebo versus GABA 15 mg/kg in A PAED and C CHIPP scores. B, D Placebo versus GABA 30 mg/kg in B PAED and D CHIPP scores.

^cStatistical tests used were Kruskal-Wallis test followed by post hoc Dunn’s test.

^dSignificant P values < 0.05.